FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Company plans to release its financial results for the three months ended June 30, 2008, on Monday, August 11, 2008 after the close of the market. In addition, the Company intends to release results from a pilot clinical study evaluating Augment Injectable Bone Graft in foot and ankle fusions. The Company will host a conference call and audio webcast to discuss these results at 4:30 EDT the same afternoon.
